Screening for the potential of a drug candidate to cause idiosyncratic drug reactions (Q35214888)

7 August 2017

1 reference

title

Screening for the potential of a drug candidate to cause idiosyncratic drug reactions (English)

1 reference

7 August 2017

0 references

Jack Uetrecht

1

1 reference

7 August 2017

publication date

1 September 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

8

1 reference

7 August 2017

issue

18

1 reference

7 August 2017

page(s)

832-837

1 reference

Timing of new black box warnings and withdrawals for prescription medications

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Hepatotoxicity with thiazolidinediones: is it a class effect?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Mechanisms of idiosyncratic drug reactions: the case of felbamate.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Safety review of adult clinical trial experience with lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Drug metabolites in safety testing

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

The immunologic and metabolic basis of drug hypersensitivities

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular, and Clinical Perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Allergic and autoimmune reactions to xenobiotics: how do they arise?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Innate immune recognition and control of adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

An innate sense of danger

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Tolerance, danger, and the extended family

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

The danger hypothesis--potential role in idiosyncratic drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Mechanisms of troglitazone hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

N-oxidation of drugs associated with idiosyncratic drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Studies on the chemical reactivity of 2-phenylpropionic acid 1-O-acyl glucuronide and S-acyl-CoA thioester metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Mass spectrometry in the analysis of glutathione conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Characterization of a potential animal model of an idiosyncratic drug reaction: nevirapine-induced skin rash in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902816-2

7 January 2021

10.1016/S1359-6446(03)02816-2

Identifiers

DOI

1 reference

release_wd2t6uk5mncvllvr76dtsn4ypa

7 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wd2t6uk5mncvllvr76dtsn4ypa

24 November 2022

mapped directly with Wikidata item

1 reference